Clinical Trial: A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors

U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07534813) titled 'A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors' on March 31.

Brief Summary: This study adopts a single-center, single-arm, open-label design. It aims to evaluate the safety and tolerability of GT307 in patients with advanced solid tumors, as well as assess its pharmacokinetic profile and efficacy, and determine the optimal dosage regimen.

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: BIOLOGICAL: GT307 injection

GT307 injection to treat advanced solid tumors

Recr...